ZIAHLM Trademark

Trademark Overview


On Tuesday, September 26, 2017, a trademark application was filed for ZIAHLM with the United States Patent and Trademark Office. The USPTO has given the ZIAHLM trademark a serial number of 87622430. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 6, 2021. This trademark is owned by Eli Lilly and Company. The ZIAHLM trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use i...
ziahlm

General Information


Serial Number87622430
Word MarkZIAHLM
Filing DateTuesday, September 26, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 6, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 6, 2018

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases and of oncology and of pain

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, September 30, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events


Event DateEvent Description
Tuesday, September 7, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, September 6, 2021ABANDONMENT - NO USE STATEMENT FILED
Wednesday, December 30, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 29, 2020EXTENSION 5 GRANTED
Monday, December 21, 2020EXTENSION 5 FILED
Monday, December 21, 2020TEAS EXTENSION RECEIVED
Tuesday, June 23, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 19, 2020EXTENSION 4 GRANTED
Friday, June 19, 2020EXTENSION 4 FILED
Friday, June 19, 2020TEAS EXTENSION RECEIVED
Friday, December 13, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 11, 2019EXTENSION 3 GRANTED
Wednesday, December 11, 2019EXTENSION 3 FILED
Wednesday, December 11, 2019TEAS EXTENSION RECEIVED
Wednesday, June 19, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 17, 2019EXTENSION 2 GRANTED
Monday, June 17, 2019EXTENSION 2 FILED
Monday, June 17, 2019TEAS EXTENSION RECEIVED
Saturday, December 22, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 21, 2018EXTENSION 1 GRANTED
Wednesday, December 12, 2018EXTENSION 1 FILED
Friday, December 21, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, December 12, 2018TEAS EXTENSION RECEIVED
Tuesday, July 31, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sunday, June 17, 2018EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Thursday, March 8, 2018EXTENSION OF TIME TO OPPOSE RECEIVED
Wednesday, February 14, 2018CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Tuesday, February 13, 2018ASSIGNED TO PETITION STAFF
Tuesday, February 6, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 6, 2018PUBLISHED FOR OPPOSITION
Thursday, February 1, 2018TEAS POST PUBLICATION AMENDMENT RECEIVED
Wednesday, January 17, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, December 22, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 15, 2017ASSIGNED TO EXAMINER
Saturday, September 30, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, September 29, 2017NEW APPLICATION ENTERED IN TRAM